Company / CapEx per Share
Gossamer Bio, Inc. CapEx per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.00
FY2025
5-year range
$0.00 / $0.02
FY2021-FY2025
Trend
-
vs FY2024
Sector context
#179 of 192
Health Care
What the data says
Among 192 Health Care companies, Gossamer Bio, Inc. is in the bottom 7% for capex per share. Improved from $0.00 to $0.00 over the past 2 years.
Based on SEC 10-K filings.
0.00 in FY2025 with a 5-year CAGR of -56.3%.
Improved from $0.00 to $0.00 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -58.4%
- 5-Year CAGR
- -56.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 7% in Health CareTop 93% of 192This company $0.00 Sector average $3.54
▼
-100.0% below sector average
Key checks
Key Insights
- Ranks #179 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2018.
- Lowest capex per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -9.62 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.00 | - |
| FY2024 | $0.00 | - |
| FY2023 | $0.00 | -100.0% |
| FY2022 | $0.00 | -76.5% |
| FY2021 | $0.02 | -5.8% |
| FY2020 | $0.02 | -59.5% |
| FY2019 | $0.05 | -89.9% |
| FY2018 | $0.54 | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026